Nanwei Medical announced that on November 12, 2026, the company received a proposal from Chairman Long Xiaohui to buy back some A shares through centralized bidding transactions for share incentives or employee stock ownership plans, and cancel them if not used up within 3 years. The total repurchase capital is not less than 20 million yuan and no more than 30 million yuan. The repurchase price does not exceed 150% of the average transaction price of the company's stock in the 30 trading days before the board of directors passed the repurchase resolution. The repurchase period is within 6 months from the date the board of directors reviews and approves the repurchase plan, and the source of funding is own funds. Long Xiaohui proposed that the company's shares were not traded in the first six months, and there were no plans to reduce holdings during the repurchase period. The board of directors will vote in favor of the repurchase bill. This repurchase is subject to approval procedures, and there is uncertainty.

Nanwei Medical announced that on November 12, 2026, the company received a proposal from Chairman Long Xiaohui to buy back some A shares through centralized bidding transactions for share incentives or employee stock ownership plans, and cancel them if not used up within 3 years. The total repurchase capital is not less than 20 million yuan and no more than 30 million yuan. The repurchase price does not exceed 150% of the average transaction price of the company's stock in the 30 trading days before the board of directors passed the repurchase resolution. The repurchase period is within 6 months from the date the board of directors reviews and approves the repurchase plan, and the source of funding is own funds. Long Xiaohui proposed that the company's shares were not traded in the first six months, and there were no plans to reduce holdings during the repurchase period. The board of directors will vote in favor of the repurchase bill. This repurchase is subject to approval procedures, and there is uncertainty.